• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于Boiss.治疗腹泻型肠易激综合征患者的双盲随机临床试验。

A double-blind randomized clinical trial of Boiss. in the patients with diarrhea-predominant irritable bowel syndrome.

作者信息

Heydari Parisa, Ghanadian Mustafa, Asghari Gholamreza, Azimi Maryam, Babaeian Mahmoud, Adibi Peyman

机构信息

Department of Persian Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

出版信息

Res Pharm Sci. 2022 Dec 24;18(1):89-99. doi: 10.4103/1735-5362.363599. eCollection 2023 Feb.

DOI:10.4103/1735-5362.363599
PMID:36846732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9951779/
Abstract

BACKGROUND AND PURPOSE

Irritable bowel syndrome (IBS) is a disease that shows its impacts on many populations worldwide. It is known as a functional disorder of the gastrointestinal tract followed by diarrhea and fecal inconsistency. Due to the lack of treatment in the allopathic medicine system for IBS, people in the western world use different herbs as alternative medicine. In the present study, we evaluated the dried extract of against IBS.

EXPERIMENTAL APPROACH

In a randomized, double-blinded, placebo-controlled clinical trial, 76 diarrhea-predominant IBS patients were randomly assigned to two equal groups: the control group (given the placebo capsule containing 250 mg of dibasic calcium phosphate) and the treatment groups (given the capsule containing 75 mg of the dry extract of and 175 mg of dibasic calcium phosphate as filler). The study was conducted based on Rome III criteria. We studied symptoms included in Rome III criteria and divided the study into the duration of drug administration and four weeks after drug administration. These groups were compared with those of the control group.

FINDINGS/RESULTS: Significant improvements were found in the quality of life, temperament, and IBS symptoms throughout the treatment duration. Quality of life, temperature, and IBS symptoms were slightly decreased in the treatment group 4 weeks after stopping the treatment. While concluding the study, we found effective against IBS.

CONCLUSION AND IMPLICATIONS

Whole extract of modulated symptoms of IBS patients and improved their quality of life.

摘要

背景与目的

肠易激综合征(IBS)是一种影响全球众多人群的疾病。它是一种胃肠道功能紊乱疾病,伴有腹泻和粪便性状异常。由于现代医学体系中缺乏针对IBS的治疗方法,西方世界的人们使用不同草药作为替代药物。在本研究中,我们评估了[草药名称未给出]的干燥提取物对IBS的疗效。

实验方法

在一项随机、双盲、安慰剂对照的临床试验中,76例腹泻型IBS患者被随机分为两组,每组人数相等:对照组(给予含250毫克磷酸氢钙的安慰剂胶囊)和治疗组(给予含75毫克[草药名称未给出]干燥提取物和175毫克磷酸氢钙作为填充剂的胶囊)。该研究基于罗马Ⅲ标准进行。我们研究了罗马Ⅲ标准中包含的症状,并将研究分为给药期和给药后四周。将这些组与对照组进行比较。

研究结果

在整个治疗期间,生活质量、情绪和IBS症状均有显著改善。治疗组在停药4周后,生活质量、情绪和IBS症状略有下降。在研究结束时,我们发现[草药名称未给出]对IBS有效。

结论与启示

[草药名称未给出]的全提取物可调节IBS患者的症状并改善其生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/65bd4ba86514/RPS-18-89-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/5af675b2fc10/RPS-18-89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/fd3ff20ea734/RPS-18-89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/65bd4ba86514/RPS-18-89-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/5af675b2fc10/RPS-18-89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/fd3ff20ea734/RPS-18-89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f536/9951779/65bd4ba86514/RPS-18-89-g003.jpg

相似文献

1
A double-blind randomized clinical trial of Boiss. in the patients with diarrhea-predominant irritable bowel syndrome.一项关于Boiss.治疗腹泻型肠易激综合征患者的双盲随机临床试验。
Res Pharm Sci. 2022 Dec 24;18(1):89-99. doi: 10.4103/1735-5362.363599. eCollection 2023 Feb.
2
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.痛泻要方治疗腹泻型肠易激综合征的随机、双盲、安慰剂对照临床试验方案
Trials. 2022 Mar 21;23(1):226. doi: 10.1186/s13063-022-06142-x.
3
Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.富含纤维的斜发沸石治疗腹泻型肠易激综合征患者的安全性和有效性:随机对照试验。
World J Gastroenterol. 2022 Dec 14;28(46):6573-6588. doi: 10.3748/wjg.v28.i46.6573.
4
Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial.草药提取物颗粒联合奥替溴铵治疗腹泻型肠易激综合征的疗效:一项随机对照试验的研究方案
BMJ Open. 2017 Dec 1;7(11):e018362. doi: 10.1136/bmjopen-2017-018362.
5
Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.通心宁颗粒()上市后再评价治疗腹泻型肠易激综合征的多中心随机双盲双模拟阳性药平行对照临床试验
Chin J Integr Med. 2019 Dec;25(12):887-894. doi: 10.1007/s11655-019-3030-x. Epub 2019 Jul 10.
6
Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.草药提取物颗粒联合益生菌混合物治疗腹泻型肠易激综合征的随机对照试验研究方案。
Trials. 2011 Oct 6;12:219. doi: 10.1186/1745-6215-12-219.
7
Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.维生素 D3 补充剂对腹泻型肠易激综合征患者的影响:对症状改善、血清促肾上腺皮质激素释放激素和白细胞介素 6 的影响——一项随机临床试验。
Complement Med Res. 2020;27(5):302-309. doi: 10.1159/000506149. Epub 2020 Mar 23.
8
Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.抗肠易激综合征糖浆改善便秘型肠易激综合征:一项随机、安慰剂对照试验。
Chin J Integr Med. 2020 Oct;26(10):729-735. doi: 10.1007/s11655-020-3267-4. Epub 2020 Jul 4.
9
Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.中药治疗腹泻型肠易激综合征:一项随机安慰剂对照试验
Am J Gastroenterol. 2006 Jul;101(7):1574-80. doi: 10.1111/j.1572-0241.2006.00576.x.
10
Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.长安Ⅰ号方(Ⅰ)治疗腹泻型肠易激综合征的疗效:一项多中心随机双盲安慰剂对照临床试验
Chin J Integr Med. 2018 Sep;24(9):645-652. doi: 10.1007/s11655-016-2596-9. Epub 2016 Aug 3.

引用本文的文献

1
Placebo response variability on health-related quality of life outcomes in irritable bowel syndrome: an arm-based network meta-analysis.肠易激综合征中与健康相关生活质量结局的安慰剂反应变异性:一项基于臂的网络荟萃分析。
Qual Life Res. 2025 Jun;34(6):1553-1568. doi: 10.1007/s11136-025-03927-w. Epub 2025 Feb 25.
2
Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.肠易激综合征临床试验中的草药安慰剂反应:一项系统评价与荟萃分析
Front Pharmacol. 2024 Nov 28;15:1475366. doi: 10.3389/fphar.2024.1475366. eCollection 2024.

本文引用的文献

1
Melatonin and calcium modulate the production of rosmarinic acid, luteolin, and apigenin in Dracocephalum kotschyi under salinity stress.褪黑素和钙可以调节盐胁迫下穗花牡荆中迷迭香酸、木犀草素和芹菜素的生成。
Phytochemistry. 2020 Sep;177:112422. doi: 10.1016/j.phytochem.2020.112422. Epub 2020 Jun 25.
2
Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial.一种新型草药治疗肠易激综合征的疗效与安全性:一项随机双盲临床试验
Gastroenterol Res Pract. 2020 May 27;2020:8213082. doi: 10.1155/2020/8213082. eCollection 2020.
3
Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
随机临床试验:库拉索芦荟提取物对肠易激综合征患者症状、粪便微生物群和粪便代谢物谱的影响。
Neurogastroenterol Motil. 2020 Aug;32(8):e13860. doi: 10.1111/nmo.13860. Epub 2020 Apr 20.
4
A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases.迷迭香酸对炎症性疾病抗炎作用的综述
Front Pharmacol. 2020 Feb 28;11:153. doi: 10.3389/fphar.2020.00153. eCollection 2020.
5
Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence.肠易激综合征和大便失禁从罗马Ⅲ标准转变为罗马Ⅳ标准的益处与缺陷
Clin Gastroenterol Hepatol. 2020 Feb;18(2):297-299. doi: 10.1016/j.cgh.2019.10.004. Epub 2019 Oct 10.
6
Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.天然多酚预防肠易激综合征的分子机制和靶点:综述
Daru. 2019 Dec;27(2):755-780. doi: 10.1007/s40199-019-00284-1. Epub 2019 Jul 4.
7
Medicinal Properties and Active Constituents of and Its Significance in Iran: A Systematic Review.[药物名称]的药用特性、活性成分及其在伊朗的意义:一项系统综述
Evid Based Complement Alternat Med. 2019 May 6;2019:9465309. doi: 10.1155/2019/9465309. eCollection 2019.
8
Therapeutic Potential of Zataria multiflora Boiss in Treatment of Irritable Bowel Syndrome (IBS).百里香治疗肠易激综合征(IBS)的治疗潜力。
J Diet Suppl. 2019;16(1):119-128. doi: 10.1080/19390211.2017.1409852. Epub 2018 Jan 15.
9
Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.罗马标准与肠易激综合征的诊断方法
J Clin Med. 2017 Oct 26;6(11):99. doi: 10.3390/jcm6110099.
10
Anti-inflammatory effect of apigenin and hydroalcoholic extract of on acetic acid-induced colitis in rats.芹菜素及水醇提取物对大鼠乙酸诱导性结肠炎的抗炎作用。 (你提供的原文中“hydroalcoholic extract of”后面似乎缺失了具体内容)
Res Pharm Sci. 2017 Aug;12(4):322-329. doi: 10.4103/1735-5362.212050.